MIME-Version: 1.0 Content-Location: file:///C:/AA89CAB4/oct_6_meeting_report.htm Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"

SOS Rx

Senior Outpatient Medication Safety&nb= sp;

Full Coalition Meeting, Octo= ber 6, 2004

Meeting Report

______________________________________________________= __________________

 

The sixth full coalition meeting of SOS Rx was held on October 6, 2004, and included more than 55 participants.  The meeting was held in the George= Meany Conference Room at the AFL-CIO Building in Washington, DC. All meeting documents, including the agenda and list of attendees, are now available at www.sosrx.org.  

 

Presentati= on

 

Dr. Mark McClellan, Administrator of the Centers for Medicare and Medicaid Services, spoke to the coalition about current CMS programs and initiatives. A question and answer session followed Dr. McClellan’s comments.   Highlights from his presentation and the discussion are listed below= .

   &nbs= p;       

·             CMS supports SOS Rx efforts to ensure that seniors use medications safely and effectively

·             E-prescribing – By 2009 all Medicare prescriptions must be filed electronically; this is a requirement for drug plans but not physicians.   Recognition of the challenge of educating patients about E-prescribi= ng and electronic health records without instilling fear in them. <= /p>

·             Personalized care for Medicare beneficiaries – CMS is working on improving knowledge of benefit coverage, including preventive care.

·             The creation of a patient portal by CMS will allow beneficiaries access through the Internet to benefit information, including claims, deductibles, unused benefits, and if they are due for a medical test or procedure.

·             The need to provide beneficiaries more information on drug safety – including drug recalls and specific safe= ty issues.  

·             Recognition that providing a drug benefit is= not enough, must also provide the tools to use the drugs safely and effectively, including medication therapy management.&n= bsp; CMS is currently working on regulations for the Medication Therapy Management Program.

·             Discussion of information management and the need for CMS to coordinate with other institutions as they develop their information technology capabilities. =  

 

Discussion= of Action Agenda

 

Progress reports from each workgroup representing the = four action agenda projects were given.  After each presentation there were questions and discussion.  Set forth bel= ow is a summary of each action agenda project and the discussions.    

 

1.  Clearinghouse of Safe Practices on High-Risk Situations – Lou Diamond, Medstat 

 Project Summary:=

Develop a clearinghous= e of safe practices for high-risk situations in the outpatient medication arena.= The clearinghouse will be a comprehensive dynamic resource to which healthcare professionals can turn for guidance on safe practices to be followed when prescribing certain medications.  The clearinghouse will also contain consumer-friendly versions of the safe practices. To initiate this project, NCL convened a subgroup of coalit= ion members and external experts to participate in a one-day meeting on March 3= 0, 2004, to frame the scope of the project.

 

The progress report by Lou Diamond included review of a Power Point presentation outlining the need, rationale, objectives, and pha= ses of development for the clearinghouse. SOS Rx is currently seeking a partner organization with the capacity to help develop and house the clearinghouse.= In the last month letters were sent out to several organizations inviting them= to become a partner.  Follow up a= nd additional outreach to potential partners will continue.  Discussion with coalition members included the following:

·             The intent of clearinghouse is to provide a quality source for information on high-risk medication use in the outpatient setting.  There is a need for quality evidence-based information on this issue to be organized and accessible.

·             Clearinghouse will include public and private sector research reports, plus generalizable information from other settings.  There will be some level of synthesis of information for the clearinghouse.   An expert panel could help develop the syntheses.

·             Host for the clearinghouse must be partner t= hat can maximize use, has credibility, management skills and content experts. <= o:p>

·             The clearinghouse will focus on safe use of medications, systems that need to be in place at every level of health care, dosing, monitoring

·             Need to consider barriers to consumers ̵= 1; how messages will be created and communicated to them.

·             Liability issue – need to clearly state the purpose of the clearinghouse to avoid liability

·             Coalition consensus for moving forward with developing the clearinghouse  =

 

Next Steps:=

= 1)      Find organization to develop a prototype of the clearinghouse,

= 2)      Use prototype to obtain funding for pilot,

= 3)      Develop and test pilot, and

= 4)      Secure funding for the full clearinghouse.

 

2.  Personal Medication Record –= Andy Barbash   =

Project Summary:

With a personal medica= tion record a patient is able to keep track of all medications (Rx, OTCs) as wel= l as vitamins and herbal supplements he or she may be taking, regardless of the = prescriber of the medications.  While there are various initiatives ongoing, standards and uniformity are needed to ensure that such records are consumer-friendly, useful and easily incorporated into the health care experience.  After reviewing an inventory of current initiatives on personal medication records, an expert = panel met in June 2004 to determine what information is critical to include in a PMR.  A model PMR has been dev= eloped based on the panel’s findings.  The coalition will promote the use and adoption of the model PMR by = all stakeholders, including consumers.  A public education campaign will encourage consumers to use personal medication records.  =

 

The progress report by An= dy Barbash noted that after the experts meeting in June,= two draft templates were developed and circulated to the PMR working group.  Based upon the group’s comme= nts, the templates were revised and are now accessible on the SOS Rx website.  These templates, along with the br= oad campaign message to keep track of all medications, will be tested in focus groups.  The results of the fo= cus groups will help inform the consumer education campaign.  There will be continued collaborat= ion with existing consumer outreach efforts.  

Discussion by the coaliti= on included the following:

 

·             There is a need for a broad-based campaign on this issue.  This PMR is a bes= t-case example of a PMR. The June 3rd meeting participants brought their expertise on this issue to the table, and helped create a model PMR template.

·             The broad message of this campaign is that consumers should keep track of their medications.  “Here are some ways to do th= is (templates), but there are other ways as well.  Whatever method you decide to help= you keep track, make sure it requires this set of information.”

·             The behavior change we hope to achieve is th= at we want patients to start keeping track of all of their medications.  If there are positive downstream e= ffects of this action, then that’s great.&n= bsp; However, the campaign itself is not focusing on use of patient medications. Coalition members advised the group that when we are seeking a behavior change the messages to consumers need to be carefully crafted.

·             Connecting for Health is considering holding= a meeting for those working in this area. The purpose of the meeting would be= to develop a common framework and ensure that our consumer messages are not conflicting. 

 

 Next Steps: =

= 1)      Continued coordination with other initiatives on integrating PMR with other efforts (National Health Council, Connecting for Health),

= 2)      Obtain funding for consumer testing of templates and production,

= 3)      Obtain funding to develop and test campaign messages, and

= 4)      Identify partners for pilot use of one or both templates.

&nbs= p;

3. Promoting Electronic Prescrib= ing  - Will Lang, American Assoc= iation of Colleges of Pharmacy

Project Summary:

To accelerate the use of E-prescribing the project will 1) adopt guid= ing principles that define and encourage a patient role, 2) promote various ong= oing initiatives supportive of those principles, 3) launch a public awareness campaign to educate patients about the flaws inherent in the current system, and 4) disseminate information to patients about the potential benefits of E-prescribing.   The full coalition will then approve and coordinate a media campaign to publicize the recommendations of the work group.  The coalition will educate patients about the benefits of E-prescrib= ing and their roles as health care consumers in advancing its use. <= o:p>

 

Will Lang <= span class=3DGramE>reported on the joint meeting between eHealth Initiative (EHI) and SOS Rx on September 15th that focused on the consumer’s role in promoting E-prescribing.  The summary of the meeting will be available on the SOS Rx website once finalized.  The group focused on identifying t= he “pain points” for the consumer in the prescribing process, and = how E-prescribing will benefit consumers. Because consumers have a lack of information on E-prescribing, there is a need to fill that gap and educate consumers on the benefits of E-prescribing so that they can eventually pres= sure providers to adopt such a system.

 =

Discussion = by coalition members focused on the importance of having coordinated consumer = messages on E-prescribing. The coalition also approved continuing to work with EHI a= s we develop a consumer education campaign on E-prescribing.  The coalition welcomes suggestions= for funding opportunities.

 =

Next Steps:=  

= 1)      Finalize summary of SOS Rx – EHI meeting on September 15th and post= on SOS Rx website,

= 2)      Continue to explore the concept of E-prescribing from the consumer perspective, and provide comments to relevant agencies and policy decision-making bodies,

= 3)      Develop a framework strategy and timeline for the development of a public education campaign on E-prescribing with SOS Rx E-prescribing work group and continued collaboration with EHI, and

= 4)      Obtain funding for the campaign. 

 

4.  Con= sumer Action– Targeting high-risk situations  - Jill Pierce, American Med= ical Women’s Association Foundation

Project Summary:

This project will educate consumers about the risks of various prod= ucts interacting with certain high-risk medications, such as warfarin.  A public education campaign will t= arget consumers taking high-risk medications and inform them that other prescript= ion and non-prescription medications they may be taking (OTCs, dietary suppleme= nts, herbals), as well as some foods, could interact with the prescribed medicat= ion.  Consumers will be provided with a = framework for discussing the risk of interactions and the importance of monitoring, w= ith their doctor, pharmacist or other health care professional.  The campaign will also target prov= iders and dispensers to 1) reaffirm the importance of interaction messages to patients and 2) provide them with techniques that can be used to enhance awareness and message compliance among their patients.   While w= arfarin will be the drug of initial focus, the resulting campaign will be a template that could be customized and applied to education used for other high-risk medications.  <= /p>

 

The progress report noted= that at the last full SOS Rx coalition meeting it was decided to develop a broader campaign to reach all stakeholders prescribing and monitoring warfarin.  Also based on the discussion at the last meeting, a campaign framework document which sets forth the background and evidence base for this project is now available on the SOS Rx website.    A consumer research fi= rm, Bearing Point, has been hired to inform the education campaign.  An outline of the research plan in= cludes the following elements:  data gathering on target population, conducting interviews with system stakehold= ers (medical directors of health plans, managers of anti-coagulation clinics), conduct focus groups with patients taking warfarin, conduct focus groups with providers, formulating messages based on the research, disseminating messages, evaluation of = the campaign.  An advisory group of coalition members will help guide the campaign.  There was a general request to the= group for data on warfarin users.  The coalition approved moving forw= ard with the campaign.

 

Discussion by coalition m= embers included:

·             Offers to provide data on warfarin users.

·             Evaluation of the campaign should include a review of patient outcomes and not just patient awareness. 

   

Next Steps:

1= )      Finalizing agreement and research plan with Bearing Point,

2= )      Move forward with implemention of the research plan,=

3= )      Finalize and convene advisory group,

4= )      Obtain additional funding.

 

Other:

·        Members may access the members-only section = of the SOS Rx Web site by using the following.  User name:  coalition   Password:  seniorsafety04

·        NCL will keep the coalition updated on the status of the various projects through email distributions and the Web site= .  

·        The next full meeting of the coalition will = be on January 12, 2005, from 10 am – 2 pm (EST) at the George Meany Conference Room, AFL= -CIO Building, 815 16th Street, N.W., i= n Washington, DC, and will be accessible via telephone conference call.